Patent Profile: VM Institute of Research Receives Patent for Method of Treating Triple Negative Breast Cancer
By EsqSocial Corporation 03/03/14
The U.S. Patent and Trademark Office recently issued U.S. Patent No. 8,642,270, which is entitled "Prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer." The '270 patent, which is...
By: McDonnell Boehnen Hulbert & Berghoff LLP